Voyager Therapeutics, Inc.
VYGR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001640266
No open-market purchases or sales by Voyager Therapeutics, Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $122.7M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Voyager Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 125
- +11 vs. Q3 2025
- Shares held
- 33.7M
- +3.58M (+11.9%) vs. Q3 2025
- Total value
- $132.6M
- −$8.27M (−5.9%) vs. Q3 2025
- New holders
- 19
- 31 more added
- Sold out
- 8
- 45 more reduced
3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VYGR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $122.7M |
| Q1 2026 | 135 | $129.4M |
| Q4 2025 | 125 | $132.6M |
| Q3 2025 | 117 | $141.1M |
| Q2 2025 | 113 | $103.1M |
| Q1 2025 | 116 | $117.4M |
| Q4 2024 | 133 | $196.2M |
| Q3 2024 | 128 | $205.9M |
| Q2 2024 | 127 | $301.6M |
| Q1 2024 | 132 | $331.1M |
| Q4 2023 | 107 | $227.5M |
| Q3 2023 | 111 | $211.2M |
| Q2 2023 | 106 | $307.7M |
| Q1 2023 | 82 | $183.8M |
| Q4 2022 | 70 | $146.2M |
| Q3 2022 | 69 | $142.9M |
| Q2 2022 | 78 | $142.3M |
| Q1 2022 | 70 | $171.3M |
| Q4 2021 | 59 | $51.3M |
| Q3 2021 | 69 | $58.6M |
| Q2 2021 | 78 | $96.8M |
| Q1 2021 | 101 | $125.7M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Voyager Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 162,112 | $637.1K | 0.00% | +4,003+2.5% | Added |
| Bank of America Corp | 176,097 | $692.1K | 0.00% | −251,333−58.8% | Reduced |
| Altshuler Shaham Ltd | 203,740 | $800.7K | 0.01% | +203,740 | New |
| Two Sigma Investments, LP | 222,713 | $875.3K | 0.00% | +81,998+58.3% | Added |
| UBS Group AG | 268,793 | $1.06M | 0.00% | −204,307−43.2% | Reduced |
| Renaissance Technologies LLC | 296,450 | $1.17M | 0.00% | +34,000+13.0% | Added |
| Goldman Sachs Group Inc | 303,133 | $1.19M | 0.00% | +5,560+1.9% | Added |
| JPMorgan Chase & Co | 326,230 | $1.28M | 0.00% | +108,819+50.1% | Added |
| Fiduciary Trust Co | 334,397 | $1.31M | 0.01% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 339,761 | $1.34M | 0.28% | +140,000+70.1% | Added |
| Northern Trust Corp | 368,546 | $1.45M | 0.00% | −26,205−6.6% | Reduced |
| Price T Rowe Associates Inc | 521,651 | $2.05M | 0.00% | −60,048−10.3% | Reduced |
| Morgan Stanley | 544,114 | $2.14M | 0.00% | −55,574−9.3% | Reduced |
| Citadel Advisors LLC | 556,646 | $2.19M | 0.00% | +158,420+39.8% | Added |
| State Street Corp | 936,266 | $3.68M | 0.00% | +10,908+1.2% | Added |
| Dimensional Fund Advisors LP | 1,084,499 | $4.26M | 0.00% | −198,657−15.5% | Reduced |
| Geode Capital Management, LLC | 1,135,188 | $4.46M | 0.00% | −13,424−1.2% | Reduced |
| Opaleye Management Inc. | 1,196,904 | $4.70M | 0.62% | +1,196,904 | New |
| Erste Asset Management GmbH | 1,195,141 | $4.72M | 0.04% | +78,348+7.0% | Added |
| Vestal Point Capital, LP | 1,475,000 | $5.80M | 0.21% | 00.0% | Unchanged |
| Millennium Management LLC | 1,880,760 | $7.39M | 0.01% | −411,943−18.0% | Reduced |
| Vanguard Group Inc | 3,266,484 | $12.8M | 0.00% | +16,418+0.5% | Added |
| Armistice Capital, LLC | 4,000,000 | $15.7M | 0.38% | −200,000−4.8% | Reduced |
| EcoR1 Capital, LLC | 4,002,847 | $15.7M | 0.72% | +3,332,544+497.2% | Added |
| BlackRock, Inc. | 5,618,365 | $22.1M | 0.00% | +11,094+0.2% | Added |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −184,203−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −27,360−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −19,937−100.0% | Sold out |
| EHP Funds Inc. | 0 | $0 | 0.00% | −12,375−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −12,144−100.0% | Sold out |
| Wexford Capital LP | 0 | $0 | 0.00% | −9,007−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −5,700−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | – | – | – | – | Not filed |
| Point72 Europe (London) LLP | – | – | – | – | Not filed |
| Point72 (DIFC) Ltd | – | – | – | – | Not filed |